Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Emre TEKGÖZ"'
Autor:
Mehmet Nur Kaya, Duygu Tecer, Muhammet Çınar, Fahrettin Bıçakcı, Emre Tekgöz, Seda Çolak, Sedat Yılmaz
Publikováno v:
Gülhane Tıp Dergisi, Vol 65, Iss 4, Pp 145-151 (2023)
Aims:The results of randomized clinical trials evaluating the effects of tocilizumab in patients with patients are inconsistent. We aimed to investigate the reliability of pre-treatment levels of prognostic nutritional index (PNI), C-reactive protein
Externí odkaz:
https://doaj.org/article/659ae8ed8b2c494c99e8b806a01777bd
Publikováno v:
Gülhane Tıp Dergisi, Vol 65, Iss 3, Pp 138-140 (2023)
Mycobacterium tuberculosis (TB) is an infectious agent that can affect several organ systems and can cause various symptoms. The most common presentation is pulmonary TB. The incidence of extrapulmonary TB has become much more common worldwide due to
Externí odkaz:
https://doaj.org/article/7ff25d39df8e40218194db5178c7f745
Autor:
Emre Tekgöz, Seda Çolak, Ramazan Acar, İsmail Ertürk, Musa Barış Aykan, Birol Yıldız, Nuri Karadurmuş, Muhammet Çınar, Sedat Yılmaz
Publikováno v:
Gülhane Tıp Dergisi, Vol 64, Iss 1, Pp 103-109 (2022)
Aims:Immune-related adverse events (irAEs) may be observed due to the mechanism of action of immune checkpoint inhibitors (ICIs). This study investigated the frequency of rheumatologic irAEs and characteristics of the patients who developed rheumatol
Externí odkaz:
https://doaj.org/article/3030bca76f0e46a9b10ac20a8c0a8cb4
Autor:
Fatma İlknur Çınar, Özlem Sinan, Sedat Yılmaz, Gülcan Bağçivan, Işıl Aydoğan, Ayşe Gül Yalçın, Emre Tekgöz, Muhammet Çınar
Publikováno v:
European Journal of Rheumatology, Vol 8, Iss 1, Pp 20-26 (2021)
Externí odkaz:
https://doaj.org/article/bfc76c3e4e4a4eb19033d030540237f3
Autor:
Seda ÇOLAK, Emre TEKGÖZ, Muhammet ÇINAR, Gülden YILMAZ, Duygu TECER, Fahrettin BIÇAKÇI, Ferhat CUCE, Gonca FİDAN, Deniz DOĞAN, Ümit SAVAŞÇI, Yakup ARSLAN, Cantürk TAŞÇI, Emel UYAR, Zehra KARACAER, Serkan ŞENKAL, Sedat YILMAZ
Publikováno v:
Volume: 5, Issue: 2 592-599
Journal of Health Sciences and Medicine
Journal of Health Sciences and Medicine
Aim: Coronavirus disease 2019 (COVID-19) is a pandemic with potential life-threatening outcomes. The current study aims to demonstrate the effect of tocilizumab in COVID-19 related cytokine storm. Material and Method: This retrospective cross-section
Autor:
Nilüfer Tekgöz, Emre Tekgöz, Seda Çolak, Müge Sezer, Elif Çelikel, Zahide Tekin, Muhammet Çınar, Sedat Yılmaz, Banu Acar
Publikováno v:
Modern Rheumatology.
ObjectivesBehçet’s disease (BD) is a multisystem disease and frequently occurs during the second–fourth decades of life, although disease onset may be seen at any age. This study aimed to analyze the influence of the age of onset on clinical man
Publikováno v:
TURKISH JOURNAL OF MEDICAL SCIENCES. 51:2357-2363
Background Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that requires lifelong colchicine treatment. Colchicine is the mainstay of the treatment which decreases the frequency and the severity of recurrent FMF attacks, a
Publikováno v:
Gulhane Medical Journal. 63:218-224
Aims: Endothelial dysfunction and atherosclerosis are well-known risk factors for cardiovascular diseases in hypertension (HT). This study investigated the relationship between ankle-brachial pressure index (ABPI) and pulse wave velocity (PWV) in pat
Publikováno v:
Archives of Rheumatology. 37:11-18
Objectives: The aim of this study was to assess the demographic and clinical characteristics of patients with adult-onset Still’s disease (AOSD) under biological treatment. Patients and methods: This retrospective cohort study included a total of 1
Autor:
Ali Hakan Durukan, Emre Tekgöz, Erdim Sertoglu, Çiğdem Yücel, Seda Colak, Yıldız Hayran, Taner Ozgurtas, Ahmet Omma
Publikováno v:
Acta Clinica Belgica. 77:387-395
The present study aims to evaluate the relationship between Behçet's uveitis and lymphangiogenesis by determining levels of Vascular endothelial growth factor-C (VEGF-C, its receptors sVEGFR-2, sVEGFR-3 and lymphangiogenesis markers podoplanin (PDPN